2023 WHO 技术文件:疟疾化学预防

2023-04-20 世界卫生组织 WHO官网 发表于香港

本文件介绍了用于开发儿童、孕妇和非免疫旅行者疟疾化学预防药物的 PPC。

中文标题:

2023 WHO 技术文件:疟疾化学预防

英文标题:

Malaria chemoprevention

发布机构:

世界卫生组织

发布日期:

2023-04-20

简要介绍:

首选产品特性”(PPC) 是激励和引导开发急需保健产品的关键工具。此处发布的 PPC 旨在阐明疟疾化学预防药物的公共卫生需求、首选特征和临床开发注意事项。世卫组织推荐了几种控制疟疾的化学预防策略,包括季节性疟疾化学预防、常年疟疾化学预防、妊娠期疟疾间歇性预防治疗和大规模药物管理。这些策略面临许多挑战,例如依从性和覆盖率不理想以及耐药性的出现和传播。本文件介绍了用于开发儿童、孕妇和非免疫旅行者疟疾化学预防药物的 PPC。

相关资料下载:
[AttachmentFileName(sort=1, fileName=2023 WHO 技术文件:疟疾化学预防.pdf)] GetToolGuiderByIdResponse(projectId=1, id=4d66b1c00310a26d, title=2023 WHO 技术文件:疟疾化学预防, enTitle=Malaria chemoprevention, guiderFrom=WHO官网, authorId=0, author=, summary=本文件介绍了用于开发儿童、孕妇和非免疫旅行者疟疾化学预防药物的 PPC。, cover=https://img.medsci.cn/Random/doctor-is-working-at-the-hospital-PAJM2K5.jpg, journalId=0, articlesId=null, associationId=138, associationName=世界卫生组织, associationIntro=null, copyright=0, guiderPublishedTime=Thu Apr 20 00:00:00 CST 2023, originalUrl=, linkOutUrl=, content=<p>首选产品特性&rdquo;(PPC) 是激励和引导开发急需保健产品的关键工具。此处发布的 PPC 旨在阐明疟疾化学预防药物的公共卫生需求、首选特征和临床开发注意事项。世卫组织推荐了几种控制疟疾的化学预防策略,包括季节性疟疾化学预防、常年疟疾化学预防、妊娠期疟疾间歇性预防治疗和大规模药物管理。这些策略面临许多挑战,例如依从性和覆盖率不理想以及耐药性的出现和传播。本文件介绍了用于开发儿童、孕妇和非免疫旅行者疟疾化学预防药物的 PPC。</p>, tagList=[TagDto(tagId=474544, tagName=疟疾化学预防)], categoryList=[CategoryDto(categoryId=9, categoryName=传染科, tenant=100), CategoryDto(categoryId=35, categoryName=预防公卫, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=5313, articleKeyword=疟疾, articleKeywordNum=6, guiderKeywordId=5313, guiderKeyword=疟疾, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=文档, guiderLanguage=1, guiderRegion=10, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=25863, appHits=165, showAppHits=0, pcHits=190, showPcHits=25697, likes=0, shares=133, comments=4, approvalStatus=1, publishedTime=Tue Apr 25 20:34:00 CST 2023, publishedTimeString=2023-04-20, pcVisible=1, appVisible=1, editorId=0, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=dajiong, createdTime=Fri Apr 21 10:36:31 CST 2023, updatedBy=4754896, updatedName=侠胆医心, updatedTime=Sun Dec 31 03:46:33 CST 2023, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=香港, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2023 WHO 技术文件:疟疾化学预防.pdf)])
2023 WHO 技术文件:疟疾化学预防.pdf
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2128484, encodeId=12d22128484b8, content=<a href='/topic/show?id=f293e0435d6' target=_blank style='color:#2F92EE;'>#疟疾#</a><a href='/topic/show?id=2dcb33531fd' target=_blank style='color:#2F92EE;'>#化学预防#</a><a href='/topic/show?id=4f811868096' target=_blank style='color:#2F92EE;'>#WHO#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70435, encryptionId=f293e0435d6, topicName=疟疾), TopicDto(id=33531, encryptionId=2dcb33531fd, topicName=化学预防), TopicDto(id=18680, encryptionId=4f811868096, topicName=WHO)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Wed Apr 26 19:37:07 CST 2023, time=2023-04-26, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2128310, encodeId=07b22128310b5, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b575324597, createdName=148b6ed5m11暂无昵称, createdTime=Tue Apr 25 21:35:25 CST 2023, time=2023-04-25, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2128303, encodeId=abc9212830375, content=疟疾防控仍然任重道远, beContent=null, objectType=guider, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02bf2579143, createdName=1259e64fm26暂无昵称, createdTime=Tue Apr 25 20:55:57 CST 2023, time=2023-04-25, status=1, ipAttribution=辽宁省)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2128484, encodeId=12d22128484b8, content=<a href='/topic/show?id=f293e0435d6' target=_blank style='color:#2F92EE;'>#疟疾#</a><a href='/topic/show?id=2dcb33531fd' target=_blank style='color:#2F92EE;'>#化学预防#</a><a href='/topic/show?id=4f811868096' target=_blank style='color:#2F92EE;'>#WHO#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70435, encryptionId=f293e0435d6, topicName=疟疾), TopicDto(id=33531, encryptionId=2dcb33531fd, topicName=化学预防), TopicDto(id=18680, encryptionId=4f811868096, topicName=WHO)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Wed Apr 26 19:37:07 CST 2023, time=2023-04-26, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2128310, encodeId=07b22128310b5, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b575324597, createdName=148b6ed5m11暂无昵称, createdTime=Tue Apr 25 21:35:25 CST 2023, time=2023-04-25, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2128303, encodeId=abc9212830375, content=疟疾防控仍然任重道远, beContent=null, objectType=guider, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02bf2579143, createdName=1259e64fm26暂无昵称, createdTime=Tue Apr 25 20:55:57 CST 2023, time=2023-04-25, status=1, ipAttribution=辽宁省)]
    2023-04-25 148b6ed5m11暂无昵称 来自辽宁省

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2128484, encodeId=12d22128484b8, content=<a href='/topic/show?id=f293e0435d6' target=_blank style='color:#2F92EE;'>#疟疾#</a><a href='/topic/show?id=2dcb33531fd' target=_blank style='color:#2F92EE;'>#化学预防#</a><a href='/topic/show?id=4f811868096' target=_blank style='color:#2F92EE;'>#WHO#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70435, encryptionId=f293e0435d6, topicName=疟疾), TopicDto(id=33531, encryptionId=2dcb33531fd, topicName=化学预防), TopicDto(id=18680, encryptionId=4f811868096, topicName=WHO)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Wed Apr 26 19:37:07 CST 2023, time=2023-04-26, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2128310, encodeId=07b22128310b5, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b575324597, createdName=148b6ed5m11暂无昵称, createdTime=Tue Apr 25 21:35:25 CST 2023, time=2023-04-25, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2128303, encodeId=abc9212830375, content=疟疾防控仍然任重道远, beContent=null, objectType=guider, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02bf2579143, createdName=1259e64fm26暂无昵称, createdTime=Tue Apr 25 20:55:57 CST 2023, time=2023-04-25, status=1, ipAttribution=辽宁省)]
    2023-04-25 1259e64fm26暂无昵称 来自辽宁省

    疟疾防控仍然任重道远

    0

拓展阅读

42℃高热背后的隐形杀手:PCT飙升竟非败血症?

44 岁男性因发热 4 天入院,曾多次患疟。初诊考虑感染性发热,后确诊卵形疟。介绍疟疾相关知识,含病原学、流行病学、临床表现、诊断、鉴别诊断、治疗及预防,强调临床易疏忽疟疾混合感染等问题。

【今日分享】2024年WHO世界疟疾报告

疟疾感染风险高的群体包括五岁以下儿童、妇女和女童、土著人民、移民、残疾人和偏远地区获得保健机会有限的人。

揭秘RTS,S疫苗抗疟新机制:性别差异与IgA抗体成关键?

近期,发表于The Lancet Microbe的一项研究在接种RTS,S疫苗的儿童中确定了与疟疾保护相关的抗体反应类型,感染前沿特此报道。

美国“疟疾”在研基金,高达272项!这个药物遗传学、耐药表观遗传学的课题设计,值得所有医生借鉴(2024)

我们仅对美国国立卫生研究院(NIH)资助的在研疟疾相关项目进行梳理,希望给同仁们的选题思路提供一点启发。

疟疾,与国家命运相关。

疟疾,一个由蚊虫叮咬感染上的疾病,发病的病人会时而寒战,时而发热,红细胞会破坏,会贫血,脾脏会增大,严重的会致死。

国家卫健委发文,基层医生有新任务

各地要高度重视,严格贯彻落实~

2022 WHO指南:疟疾

世界卫生组织(WHO,The World Health Organization) · 2022-02-18

2022 BSH指南:疟疾的实验室诊断

英国血液病学学会(BSH,British Society for Haematology) · 2022-03-09

2022 WHO指南:疟疾(6月)

世界卫生组织(WHO,The World Health Organization) · 2022-06-03

疟疾诊疗指南

浙江大学医学院附属第一医院 · 2022-07-29

疟疾诊疗指南(更新版)

国家传染病医学中心撰写组 · 2022-08-23

2022 WHO指南:疟疾(11月更新)

世界卫生组织(WHO,The World Health Organization) · 2022-11-25